Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome

BACKGROUND: Atypical hemolytic uremic syndrome (HUS) is associated with high recurrence rates after kidney transplant, with devastating outcomes. In late 2011, experts in France recommended the use of highly individualized complement blockade–based prophylaxis with eculizumab to prevent post-transpl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Soc Nephrol
Main Authors: Zuber, Julien, Frimat, Marie, Caillard, Sophie, Kamar, Nassim, Gatault, Philippe, Petitprez, Florent, Couzi, Lionel, Jourde-Chiche, Noemie, Chatelet, Valérie, Gaisne, Raphael, Bertrand, Dominique, Bamoulid, Jamal, Louis, Magali, Sberro Soussan, Rebecca, Navarro, David, Westeel, Pierre-Francois, Frimat, Luc, Colosio, Charlotte, Thierry, Antoine, Rivalan, Joseph, Albano, Laetitia, Arzouk, Nadia, Cornec-Le Gall, Emilie, Claisse, Guillaume, Elias, Michelle, El Karoui, Khalil, Chauvet, Sophie, Coindre, Jean-Philippe, Rerolle, Jean-Philippe, Tricot, Leila, Sayegh, Johnny, Garrouste, Cyril, Charasse, Christophe, Delmas, Yahsou, Massy, Ziad, Hourmant, Maryvonne, Servais, Aude, Loirat, Chantal, Fakhouri, Fadi, Pouteil-Noble, Claire, Peraldi, Marie-Noelle, Legendre, Christophe, Rondeau, Eric, Le Quintrec, Moglie, Frémeaux-Bacchi, Véronique
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2019
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900783/
https://ncbi.nlm.nih.gov/pubmed/31575699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2019040331
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados